Followers | 313 |
Posts | 14345 |
Boards Moderated | 0 |
Alias Born | 10/17/2013 |
Thursday, January 12, 2017 8:10:56 PM
Ms. Kathleen Roberton has been the Chief Executive Officer, President and Director at Cantor Group Inc since January 14, 2016. Ms. Roberton has an extensive background as an Officer and Director of public companies.
http://www.bloomberg.com/research/stocks/people/person.asp?personId=322463071&privcapId=33364811
So that being said ....
Feb 2016 ...
This was in her bio..it said feb 2015, but she didn't even become CEO of MEDH until 2016...
Here's probably the next PR update of her completion....I'm sure of it...it has to be; ( 49 state licensing ) and guess what..... Its due in less than 3 weeks!!!
( smiling)!!!
MedX will advance to be licensed in up to 49 other states within the next 12 months.
MedX has structured agreements with Amneal Pharmaceuticals and Gemini Laboratories who are the FDA Approved Manufactures of Finished Dosed Drugs. Phase Two: We have 3 products to launch in the OTC realm, two we will manufacture and one we will have a licensing agreement on. This may prove to be our largest sector as a couple products are suited for Kathleen Roberton’s contacts who own very large network marketing companies.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM